Cargando…
Expression of Human epidermal growth factor receptor 2, Survivin, Enhancer of zeste homolog -2, Cyclooxygenase-2, p53 and p16 molecular markers in Gall bladder carcinoma
INTRODUCTION: Gallbladder cancer exhibits striking variability in the global rates, reaching epidemic levels for some regions and ethnicities. The basis of its variability resides in differences in environmental exposure and intrinsic genetic predisposition to carcinogenesis. There is little informa...
Autores principales: | Gupta, Amit, Gupta, Sweety, Mani, Rishit, Durgapal, Prashant, Goyal, Bela, Rajput, Deepak, Rao, Shalinee, Dhar, Puneet, Gupta, Manoj, Kishore, Sanjeev, Kant, Ravi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312376/ https://www.ncbi.nlm.nih.gov/pubmed/34321957 http://dx.doi.org/10.4103/jcar.JCar_4_21 |
Ejemplares similares
-
Expression and clinicopathological correlation of Ki-67 in gallbladder carcinoma
por: Gupta, Amit, et al.
Publicado: (2021) -
Role of carbohydrate antigen 19-9, carcinoembryonic antigen, and carbohydrate antigen 125 as the predictors of resectability and survival in the patients of Carcinoma Gall Bladder
por: Agrawal, Saumya, et al.
Publicado: (2020) -
Evaluation of platelet distribution width as novel biomarker in gall bladder cancer
por: Siddeek, Rohik Anjum T., et al.
Publicado: (2020) -
The State of Perplexity During Management of Gall Bladder Malignancy in an Expectant Young Mother
por: Rajput, Deepak, et al.
Publicado: (2021) -
Symptom Palliation in Advanced GallBladder Cancer: An Institutional Experience
por: Gupta, Amit, et al.
Publicado: (2019)